Trinav Infusion System
Payments companies reported to CMS as associated with Trinav Infusion System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Trinav Infusion System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Trinav Infusion System
These are the largest totals companies reported as associated with Trinav Infusion System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Riad Salem | Chicago, IL | Vascular & Interventional Radiology | $265,484.07 |
| Robert Lewandowski | Chicago, IL | Vascular & Interventional Radiology | $261,196.15 |
| Alexander Kim | Oxon Hill, MD | Vascular & Interventional Radiology | $253,641.17 |
| Richard Marshall Jr | New Orleans, LA | Vascular & Interventional Radiology | $198,140.30 |
| Dennis Griffin | Englewood, CO | Diagnostic Radiology | $162,359.69 |
| David Porter | Greenwood Village, CO | Diagnostic Radiology | $133,652.46 |
| James Luethke | Englewood, CO | Diagnostic Radiology | $126,920.00 |
| Rekha Abichandani | Cambridge, MA | Nephrology (Internal Medicine) | $126,316.68 |
| Jonathan Lewis | Westport, CT | Surgical Oncology | $114,750.00 |
| John Hardaway | Shenandoah, TX | Surgical Oncology | $96,247.84 |
Prescribed Trinav Infusion System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.